Identifying women with undetected ovarian cancer: Independent and external validation of QCancer® (Ovarian) prediction model

European Journal of Cancer Care

Volumn 22, Issue 4, 2013, Pages 423-429

  Collins, G S ^a   Altman, D G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Diagnosis; External validation; Ovarian cancer; QCancer; Risk prediction

Indexed keywords

ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; COHORT ANALYSIS; DELAYED DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; GENERAL PRACTICE; HUMAN; INCIDENCE; METHODOLOGY; MIDDLE AGED; OVARY TUMOR; PREDICTIVE VALUE; PRIMARY HEALTH CARE; REPRODUCIBILITY; RISK ASSESSMENT; STATISTICS; UNITED KINGDOM; VALIDATION STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DELAYED DIAGNOSIS; EARLY DETECTION OF CANCER; FEMALE; GENERAL PRACTICE; GREAT BRITAIN; HUMANS; INCIDENCE; MIDDLE AGED; MODELS, BIOLOGICAL; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 84879478159     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/ecc.12015     Document Type: Article

References (21)

1. Abdel-Rahman M., Stockton D., Rachet B., Hakulinen T. & Coleman M.P. (2009) What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? British Journal of Cancer 101, S115-S124.
2. Berrino F., De Angelis R., Sant M., Rosso S., Bielska-Lasota M., Coebergh J.W. & Santaquilani M. (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. The Lancet Oncology 8, 773-783.
3. Burton A. & Altman D.G. (2004) Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. British Journal of Cancer 91, 4-8.
4. Collins G.S. & Altman D.G. (2012) Identifying patients with undetected colorectal cancer: an independent validation of QCancer (colorectal). British Journal of Cancer 107, 260-265.
5. Goff B.A., Mandel L.S., Melancon C.H. & Muntz H.G. (2004) Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA: The Journal of the American Medical Association 291, 2705-2712.
6. Goff B.A., Mandel L.S., Drescher C.W., Urban N., Gough S., Schurman K.M., Patras J., Mahony B.S. & Andersen M.R. (2007) Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 109, 221-227.
7. Hippisley-Cox J. & Coupland C. (2011) Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm. BMJ (Clinical Research Ed.) 344, d8009.
8. Janssen K.J., Donders A.R., Harrell F.E., Vergouwe Y., Chen Q., Grobbee D.E. & Moons K.G. (2010) Missing covariate data in medical research: to impute is better than to ignore. Journal of Clinical Epidemiology 63, 721-727.
9. Jemal A., Center M.M., Desantis C. & Ward E.M. (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology, Biomarkers & Prevention 19, 1893-1907.
10. Lim A.W., Mesher D., Gentry-Maharaj A., Balogun N., Jacobs I., Menon U. & Sasieni P. (2012) Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes. Journal of the National Cancer Institute doi: 10.1093/jnci/djr486.
11. Marshall A., Altman D.G., Royston P. & Holder R.L. (2010) Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study. BMC Medical Research Methodology 10, 7.
12. National Institute for Health and Clinical Excellence (2011) Ovarian Cancer: The Recognition and Initial Management of Ovarian Cancer. National Institute for Health and Clinical Excellence, London, UK.
13. Olson S.H., Mignone L., Nakaraseive C., Caputo T.A., Barakat R.R. & Harlap S. (2001) Symptoms of ovarian cancer. Obstetrics and Gynecology 98, 212-217.
14. R Development Core Team (2012) R: A Language and Environment for Statistical Computing. ISBN 3-900051-07-0. Available at: http://www.R-project.org, Vienna, Austria.
15. Richards M.A. (2009) The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. British Journal of Cancer 101, S1-S4.
16. Rossing M.A., Wicklund K.G., Cushing-Haugen K.L. & Weiss N.S. (2010) Predictive value of symptoms for early detection of ovarian cancer. Journal of the National Cancer Institute 102, 222-229.
17. Royston P. (2006) Explained variation for survival models. Stata Journal 6, 83-96.
18. Royston P. & Sauerbrei W. (2004) A new measure of prognostic separation in survival data. Statistics in Medicine 23, 723-748.
19. Statacorp (2009) StataCorp. Stata statistical software: release 11.
20. Twombly R. (2007) Cancer killer may be 'silent' no more. Journal of the National Cancer Institute 99, 1359-1361.
21. Vergouwe Y., Royston P., Moons K.G.M. & Altman D.G. (2010) Development and validation of a prediction model with missing predictor data: a practical approach. Journal of Clinical Epidemiology 63, 205-214.